Hajdúch M - Search Results

1

Anticancer activity of natural cytokinins: a structure-activity relationship study.

Voller J, Zatloukal M, Lenobel R, Dolezal K, Béres T, Krystof V, Spíchal L, Niemann P, Dzubák P, Hajdúch M, Strnad M. Voller J, et al. Among authors: hajduch m. Phytochemistry. 2010 Aug;71(11-12):1350-9. doi: 10.1016/j.phytochem.2010.04.018. Epub 2010 Jun 1. Phytochemistry. 2010. PMID: 20553699

2

Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin-dependent kinase inhibitor olomoucine.

Hajdúch M, Kolár Z, Novotný R, Hanus J, Mihál V, Hlobílková A, Nosková V, Strnad M. Hajdúch M, et al. Anticancer Drugs. 1997 Nov;8(10):1007-13. doi: 10.1097/00001813-199711000-00012. Anticancer Drugs. 1997. PMID: 9436644

3

Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs.

Hajdúch M, Havlíèek L, Veselý J, Novotný R, Mihál V, Strnad M. Hajdúch M, et al. Adv Exp Med Biol. 1999;457:341-53. Adv Exp Med Biol. 1999. PMID: 10500810 Review.

4

Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine.

Kovárová H, Hajdúch M, Korínková G, Halada P, Krupicková S, Gouldsworthy A, Zhelev N, Strnad M. Kovárová H, et al. Among authors: hajduch m. Electrophoresis. 2000 Nov;21(17):3757-64. doi: 10.1002/1522-2683(200011)21:17<3757::AID-ELPS3757>3.0.CO;2-X. Electrophoresis. 2000. PMID: 11271495

5

Prostate cancer and the food supplement, PC-SPES. Minireview.

Thomson JO, Dzubak P, Hajduch M. Thomson JO, et al. Among authors: hajduch m. Neoplasma. 2002;49(2):69-74. Neoplasma. 2002. PMID: 12088108 Review.

6

Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.

Mad'arová J, Lukesová M, Hlobilková A, Strnad M, Vojtesek B, Lenobel R, Hajdúch M, Murray PG, Perera S, Kolár Z. Mad'arová J, et al. Among authors: hajduch m. Mol Pathol. 2002 Aug;55(4):227-34. doi: 10.1136/mp.55.4.227. Mol Pathol. 2002. PMID: 12147712 Free PMC article.

7

In vitro chemoresistance profile and expression/function of MDR associated proteins in resistant cell lines derived from CCRF-CEM, K562, A549 and MDA MB 231 parental cells.

Noskova V, Dzubak P, Kuzmina G, Ludkova A, Stehlik D, Trojanec R, Janostakova A, Korinkova G, Mihal V, Hajduch M. Noskova V, et al. Among authors: hajduch m. Neoplasma. 2002;49(6):418-25. Neoplasma. 2002. PMID: 12584592

8

Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine.

Kovarova H, Halada P, Man P, Dzubak P, Hajduch M. Kovarova H, et al. Among authors: hajduch m. Technol Cancer Res Treat. 2002 Aug;1(4):247-56. doi: 10.1177/153303460200100405. Technol Cancer Res Treat. 2002. PMID: 12625783 Free article.

9

Analysis of state-specific phosphorylation of proteins by two-dimensional gel electrophoresis approach.

Kovarova H, Hajduch M, Livingstone M, Dzubak P, Lefkovits I. Kovarova H, et al. Among authors: hajduch m. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Apr 5;787(1):53-61. doi: 10.1016/s1570-0232(02)00729-8. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12659733

10

New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships.

Sarek J, Klinot J, Dzubák P, Klinotová E, Nosková V, Krecek V, Korínková G, Thomson JO, Janost'áková A, Wang S, Parsons S, Fischer PM, Zhelev NZ, Hajdúch M. Sarek J, et al. Among authors: hajduch m. J Med Chem. 2003 Dec 4;46(25):5402-15. doi: 10.1021/jm020854p. J Med Chem. 2003. PMID: 14640549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

377 results

Search Page